Despite asset growth being largely internally funded via retained earnings, the company's liquidity position is precarious, with a current ratio of 2.08 masking just $1.1 million in cash against $278.6 million in total liabilities.
John B. Sanfilippo & Son, Inc. (JBSS) balance sheet — 30-year assets, liabilities & shareholders' equity history
| Metric | TTM | Jun'25 | Jun'24 | Jun'23 | Jun'22 | Jun'21 | Jun'20 | Jun'19 | Jun'18 | Jun'17 | Jun'16 | Jun'15 | Jun'14 | Jun'13 | Jun'12 | Jun'11 | Jun'10 | Jun'09 | Jun'08 | Jun'07 | Jun'06 | Jun'05 | Jun'04 | Jun'03 | Jun'02 | Jun'01 | Jun'00 | Jun'99 | Jun'98 | Jun'97 | Dec'95 |
|---|
| Total Current Assets | 349.31M | 346.42M | 294.08M | 254.43M | 283.16M | 225.17M | 238.87M | 225.34M | 247.8M | 253.38M | 242.17M | 284.31M | 249.37M | 223.79M | 206.82M | 177.25M | 164.78M | 147.8M | 172.15M | 188.69M | 213.76M | 261.92M | 167.63M | 147.52M | 128.78M | 129M | 134.56M | 118.5M | 128.9M | 93.7M | 126.4M |
| Cash & Short-Term Investments | 1.15M | 585K | 484K | 1.95M | 415K | 672K | 1.53M | 1.59M | 1.45M | 1.96M | 2.22M | 1.95M | 1.88M | 834K | 2.46M | 1.32M | 1.44M | 863K | 716K | 2.36M | 2.23M | 1.89M | 2.08M | 2.45M | 1.27M | 1.1M | 1.11M | 1.4M | 500K | 600K | 400K |
| Cash Only | 1.15M | 585K | 484K | 1.95M | 415K | 672K | 1.53M | 1.59M | 1.45M | 1.96M | 2.22M | 1.95M | 1.88M | 834K | 2.46M | 1.32M | 1.44M | 863K | 716K | 2.36M | 2.23M | 1.89M | 2.08M | 2.45M | 1.27M | 1.1M | 1.11M | 1.4M | 500K | 600K | 400K |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 84.47M | 76.81M | 84.96M | 72.73M | 69.61M | 66.41M | 56.95M | 60.97M | 65.43M | 64.83M | 78.09M | 75.64M | 55.8M | 49.51M | 49.87M | 39.03M | 42.18M | 34.76M | 34.65M | 42.74M | 41.91M | 39M | 34.68M | 29.61M | 24.13M | 25.89M | 24.07M | 24.2M | 23.9M | 25.2M | 27.8M |
| Days Sales Outstanding | 25.92 | 25.32 | 29.07 | 26.56 | 26.58 | 28.23 | 23.62 | 25.4 | 26.87 | 27.95 | 29.94 | 31.12 | 26.16 | 24.61 | 25.98 | 21.13 | 27.41 | 22.91 | 23.34 | 28.81 | 26.39 | 24.47 | 24.3 | 26.46 | 25.66 | 27.68 | 26.36 | 27.67 | 27.48 | 69.11 | 36.54 |
| Inventory | 245.83M | 254.6M | 196.56M | 172.94M | 204.85M | 148M | 172.07M | 157.02M | 174.62M | 182.42M | 156.57M | 198M | 182.83M | 158.71M | 146.38M | 128.94M | 114.36M | 106.29M | 127.03M | 134.16M | 164.39M | 217.62M | 127.46M | 112.02M | 99.48M | 98.57M | 105.76M | 89M | 99.5M | 63M | 96.4M |
| Days Inventory Outstanding | 91.64 | 102.82 | 84.14 | 80.1 | 98.87 | 80.21 | 89.17 | 79.83 | 85.01 | 94.48 | 70.16 | 95.7 | 101.76 | 94.29 | 90.02 | 79.76 | 89.41 | 80.58 | 97.5 | 97.89 | 110.72 | 157.82 | 108.45 | 117.81 | 123.12 | 127 | 146.3 | 124.75 | 143.95 | 214.31 | 157.71 |
| Other Current Assets | 17.87M | -159K | 12.08M | 6.81M | 1 | 1.52M | 0 | 0 | 0 | 0 | 0 | 4.26M | 3.48M | 9.9M | 4.82M | 4.88M | 4.49M | 4.11M | 8.16M | 7.71M | 2.98M | 1.74M | 1.3M | 1.26M | 861K | 1.51M | 3.62M | 3.9M | 5M | 4.9M | 1.8M |
| Total Non-Current Assets | 309.27M | 251.18M | 221.49M | 170.86M | 164.1M | 173.29M | 168.59M | 165.96M | 167.97M | 144.68M | 149.23M | 147.63M | 145.24M | 150.95M | 164.91M | 174.54M | 193.5M | 174.9M | 178.63M | 179.16M | 177.68M | 132.56M | 77.49M | 76.2M | 78.03M | 81.24M | 81.25M | 86.7M | 90.8M | 93.7M | 92.6M |
| Property, Plant & Equipment | 251.43M | 176.92M | 178.62M | 127.22M | 119.38M | 120.56M | 111.04M | 108.35M | 106.62M | 106.21M | 109.76M | 110.19M | 108.82M | 111.42M | 117.27M | 123.35M | 132.96M | 166.34M | 141.73M | 171.59M | 156.86M | 117.77M | 69.15M | 67.12M | 67.46M | 70.65M | 69.76M | 72.77M | 75.6M | 78.5M | 77M |
| Fixed Asset Turnover | 5.36x | 6.26x | 5.97x | 7.86x | 8.01x | 7.12x | 7.93x | 8.09x | 8.33x | 7.97x | 8.67x | 8.05x | 7.15x | 6.59x | 5.97x | 5.47x | 4.22x | 3.33x | 3.82x | 3.15x | 3.69x | 4.94x | 7.53x | 6.09x | 5.09x | 4.83x | 4.78x | 4.39x | 4.20x | 1.70x | 3.61x |
| Goodwill | 11.75M | 11.75M | 11.75M | 11.75M | 9.65M | 9.65M | 9.65M | 9.65M | 9.65M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.45M | 0 | 0 | 0 | 1.24M | 0 | 0 | 0 | 0 | 5.35M | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 3.39M | 4.43M | 5.82M | 6.66M | 8.06M | 9.96M | 12.13M | 14.63M | 17.65M | 0 | 1.37M | 3.08M | 5.25M | 7.88M | 10.94M | 13.92M | 16.12M | 569K | 995K | 1.42M | 8.04M | 2.27M | 3.94M | 4.37M | 4.8M | 0 | 6.13M | 6.94M | 7.8M | 8.7M | 9.5M |
| Long-Term Investments | 87.37M | 29.12M | 29.12M | 29.12M | 29.12M | 29.12M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7.72M | 7.98M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 13.58M | 23.18M | -6.96M | -7.49M | -5.36M | -2.09M | 28.98M | 27.61M | 29.03M | 29.38M | 29.27M | 31.17M | 30.44M | 30.83M | 36.7M | 37.27M | 31.24M | 0 | 35.91M | 6.14M | 12.25M | 11.27M | 4.4M | 4.72M | 5.77M | 5.25M | 5.36M | 7.01M | 7.4M | 6.5M | 6.1M |
| Total Assets | 658.58M | 597.6M | 515.58M | 425.29M | 447.26M | 398.45M | 407.46M | 391.3M | 415.77M | 398.06M | 391.41M | 431.94M | 394.61M | 374.74M | 371.73M | 351.79M | 358.28M | 322.7M | 350.78M | 367.85M | 391.45M | 394.47M | 245.12M | 223.73M | 206.81M | 210.24M | 215.81M | 205.2M | 219.7M | 187.4M | 219M |
| Asset Turnover | 1.86x | 1.85x | 2.07x | 2.35x | 2.14x | 2.15x | 2.16x | 2.24x | 2.14x | 2.13x | 2.43x | 2.05x | 1.97x | 1.96x | 1.88x | 1.92x | 1.57x | 1.72x | 1.54x | 1.47x | 1.48x | 1.47x | 2.12x | 1.83x | 1.66x | 1.62x | 1.54x | 1.56x | 1.44x | 0.71x | 1.27x |
| Asset Growth % | 49.05% | 15.91% | 21.23% | -4.91% | 12.25% | -2.21% | 4.13% | -5.89% | 4.45% | 1.7% | -9.38% | 9.46% | 5.3% | 0.81% | 5.67% | -1.81% | 11.03% | -8.01% | -4.64% | -6.03% | -0.77% | 60.93% | 9.56% | 8.18% | -1.63% | -2.58% | 5.17% | -6.6% | 17.24% | -14.43% | 9.66% |
| Total Current Liabilities | 167.93M | 156.05M | 125.94M | 85.69M | 122.76M | 100.2M | 112.17M | 83.91M | 117.19M | 109.87M | 83.26M | 134.1M | 112.23M | 108.8M | 119.71M | 111.91M | 115.63M | 95.1M | 129.29M | 173.33M | 135.73M | 124.15M | 44.77M | 72.34M | 61.39M | 73.94M | 74.39M | 65M | 76M | 43.8M | 68.2M |
| Accounts Payable | 72.44M | 60.48M | 53.44M | 42.68M | 47.72M | 48.86M | 36.32M | 42.55M | 60.34M | 50.05M | 43.72M | 45.72M | 44.91M | 43.74M | 33.04M | 28.26M | 29.63M | 23.48M | 25.36M | 21.26M | 27.94M | 29.91M | 16.39M | 13.66M | 17.74M | 11.43M | 11.85M | 9.84M | 12M | 11.2M | 26.7M |
| Days Payables Outstanding | 26.21 | 24.43 | 22.87 | 19.77 | 23.03 | 26.48 | 18.82 | 21.63 | 29.37 | 25.92 | 19.59 | 22.1 | 25 | 25.99 | 20.32 | 17.48 | 23.16 | 17.8 | 19.46 | 15.52 | 18.82 | 21.69 | 13.94 | 14.36 | 21.96 | 14.73 | 16.39 | 13.79 | 17.36 | 38.1 | 43.68 |
| Short-Term Debt | 45.13M | 63.33M | 21.7M | 957K | 43.8M | 13.62M | 34.33M | 8.24M | 40.51M | 33.81M | 16.24M | 65.57M | 46.3M | 41.61M | 60.52M | 60.43M | 58.05M | 50.55M | 84.5M | 133.27M | 146.36M | 80.22M | 14.47M | 40.48M | 29.2M | 50.2M | 47.58M | 42.08M | 54.8M | 24M | 32.2M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 15.71M | 13.79M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -12.72M | 10.18M | 15.87M | 0 | 12.58M | 0 | 0 | 795K | 0 | 5.51M | 4.35M | 4.94M | 14.96M | 13.06M | 9.2M | 8.6M | 9.3M |
| Current Ratio | 2.08x | 2.22x | 2.34x | 2.97x | 2.31x | 2.25x | 2.13x | 2.69x | 2.11x | 2.31x | 2.91x | 2.12x | 2.22x | 2.06x | 1.73x | 1.58x | 1.43x | 1.55x | 1.33x | 1.09x | 1.57x | 2.11x | 3.74x | 2.04x | 2.10x | 1.74x | 1.81x | 1.82x | 1.70x | 2.14x | 1.85x |
| Quick Ratio | 0.62x | 0.59x | 0.77x | 0.95x | 0.64x | 0.77x | 0.60x | 0.81x | 0.62x | 0.65x | 1.03x | 0.64x | 0.59x | 0.60x | 0.50x | 0.43x | 0.44x | 0.44x | 0.35x | 0.31x | 0.36x | 0.36x | 0.90x | 0.49x | 0.48x | 0.41x | 0.39x | 0.45x | 0.39x | 0.70x | 0.44x |
| Cash Conversion Cycle | 91.34 | 103.72 | 90.34 | 86.89 | 102.42 | 81.96 | 93.97 | 83.6 | 82.51 | 96.51 | 80.5 | 104.71 | 102.93 | 92.91 | 95.68 | 83.41 | 93.66 | 85.69 | 101.38 | 111.19 | 118.3 | 160.61 | 118.81 | 129.9 | 126.83 | 139.95 | 156.26 | 138.63 | 154.07 | 245.31 | 150.57 |
| Total Non-Current Liabilities | 110.7M | 80.86M | 67.02M | 47.39M | 45.68M | 55.76M | 57.05M | 52.84M | 55.66M | 52.72M | 56.95M | 56.55M | 55.55M | 50.64M | 51.01M | 56.17M | 62.76M | 62.1M | 63.13M | 31.63M | 73.32M | 74.14M | 18.99M | 32.6M | 43.37M | 41.95M | 54.67M | 60.2M | 65.5M | 70.5M | 75.2M |
| Long-Term Debt | 43.57M | 14.56M | 6.37M | 7.1M | 7.77M | 10.86M | 14.73M | 20.38M | 27.36M | 25.21M | 28.7M | 32.29M | 35.67M | 33.66M | 36.21M | 42.43M | 42.68M | 49.02M | 52.36M | 19.78M | 5.62M | 67M | 12.62M | 29.64M | 40.42M | 39.11M | 51.78M | 57.5M | 63.2M | 68.9M | 74.7M |
| Capital Lease Obligations | 89.22M | 24.22M | 24.88M | 4.77M | 1.08M | 2.1M | 2.99M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -13.34M | 0 | -9.95M | 0 | 0 | 0 | 4.4M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 11.07M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 460K | 2.05M | 4.57M | 3.63M | 2.6M | 2.61M | 5.88M | 7.14M | 6.37M | 2.96M | 2.95M | 2.84M | 2.89M | 2.7M | 2.3M | 1.7M | 500K |
| Other Non-Current Liabilities | 46.48M | 42.07M | 35.78M | 35.52M | 36.83M | 42.8M | 39.33M | 32.46M | 28.3M | 27.51M | 28.07M | 24.26M | 19.89M | 16.98M | 1.01M | 3.17M | 5.56M | 1.35M | 8.17M | 9.24M | 63.31M | 0 | 0 | 0 | 0 | 0 | 0 | 46K | 0 | -100K | 0 |
| Total Liabilities | 278.63M | 236.91M | 192.96M | 133.08M | 168.44M | 155.96M | 169.22M | 136.75M | 172.85M | 162.59M | 140.21M | 190.66M | 167.78M | 159.44M | 170.71M | 168.08M | 178.39M | 157.2M | 192.41M | 204.96M | 209.06M | 198.3M | 63.76M | 104.95M | 104.75M | 115.89M | 129.06M | 125.2M | 141.5M | 114.3M | 143.4M |
| Total Debt | 109.35M | 102.12M | 52.94M | 12.83M | 52.65M | 26.58M | 52.05M | 28.62M | 67.86M | 59.02M | 44.94M | 97.86M | 81.97M | 75.27M | 109.45M | 102.86M | 100.73M | 99.57M | 136.85M | 153.05M | 151.98M | 147.22M | 27.09M | 70.12M | 69.62M | 89.31M | 99.36M | 99.59M | 118M | 92.9M | 106.9M |
| Net Debt | 108.2M | 101.54M | 52.46M | 10.88M | 52.24M | 25.91M | 50.52M | 27.03M | 66.42M | 57.06M | 42.72M | 95.91M | 80.09M | 74.44M | 106.99M | 101.54M | 99.29M | 98.71M | 136.14M | 150.69M | 149.75M | 145.34M | 25.01M | 67.67M | 68.35M | 88.21M | 98.24M | 98.2M | 117.5M | 92.3M | 106.5M |
| Debt / Equity | 0.29x | 0.28x | 0.16x | 0.04x | 0.19x | 0.11x | 0.22x | 0.11x | 0.28x | 0.25x | 0.18x | 0.41x | 0.36x | 0.35x | 0.54x | 0.56x | 0.56x | 0.60x | 0.86x | 0.94x | 0.83x | 0.75x | 0.15x | 0.59x | 0.68x | 0.95x | 1.15x | 1.24x | 1.51x | 1.27x | 1.41x |
| Debt / EBITDA | 0.91x | 0.88x | 0.47x | 0.11x | 0.49x | 0.26x | 0.54x | 0.40x | 0.95x | 0.80x | 0.66x | 1.44x | 1.30x | 1.29x | 2.19x | 3.78x | 2.21x | 3.16x | 5.18x | 66.40x | - | 3.97x | 0.52x | 1.75x | 2.63x | 3.10x | 3.71x | 5.03x | 4.70x | 10.32x | 4.40x |
| Net Debt / EBITDA | 0.90x | 0.87x | 0.47x | 0.10x | 0.49x | 0.25x | 0.52x | 0.38x | 0.93x | 0.77x | 0.63x | 1.41x | 1.27x | 1.28x | 2.14x | 3.73x | 2.18x | 3.13x | 5.15x | 65.38x | - | 3.92x | 0.48x | 1.69x | 2.58x | 3.06x | 3.67x | 4.96x | 4.68x | 10.26x | 4.38x |
| Interest Coverage | 35.16x | 22.92x | 32.36x | 40.53x | 43.53x | 56.39x | 37.26x | 18.13x | 15.25x | 19.60x | 14.31x | 12.31x | 9.77x | 8.42x | 5.89x | 1.43x | 5.05x | 1.87x | 0.35x | -1.26x | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 379.95M | 360.7M | 322.61M | 292.21M | 278.82M | 242.49M | 238.24M | 254.56M | 242.92M | 235.47M | 251.19M | 241.28M | 226.83M | 215.3M | 201.01M | 183.71M | 179.89M | 165.5M | 158.37M | 162.89M | 182.39M | 196.18M | 181.36M | 118.78M | 102.06M | 94.35M | 86.75M | 80M | 78.2M | 73.1M | 75.6M |
| Equity Growth % | 47.56% | 11.8% | 10.41% | 4.8% | 14.98% | 1.79% | -6.41% | 4.79% | 3.17% | -6.26% | 4.11% | 6.37% | 5.35% | 7.11% | 9.42% | 2.12% | 8.7% | 4.5% | -2.77% | -10.69% | -7.03% | 8.17% | 52.68% | 16.38% | 8.18% | 8.75% | 8.44% | 2.3% | 6.98% | -3.31% | 11.01% |
| Book Value per Share | 32.26 | 30.77 | 27.60 | 25.10 | 24.05 | 20.98 | 20.65 | 22.13 | 21.22 | 20.65 | 22.16 | 21.45 | 20.38 | 19.59 | 18.56 | 17.06 | 16.77 | 15.56 | 14.93 | 15.37 | 17.23 | 18.30 | 18.58 | 12.73 | 11.15 | 10.31 | 9.48 | 8.74 | 8.53 | 7.31 | 8.21 |
| Total Shareholders' Equity | 379.95M | 360.7M | 322.61M | 292.21M | 278.82M | 242.49M | 238.24M | 254.56M | 242.92M | 235.47M | 251.19M | 241.28M | 226.83M | 215.3M | 201.01M | 183.71M | 179.89M | 165.5M | 158.37M | 162.89M | 182.39M | 196.18M | 181.36M | 118.78M | 102.06M | 94.35M | 86.75M | 80M | 78.2M | 73.1M | 75.6M |
| Common Stock | 118K | 118K | 117K | 117K | 116K | 116K | 115K | 115K | 115K | 114K | 113K | 112K | 111K | 110K | 109K | 108K | 108K | 107K | 107K | 107K | 107K | 107K | 107K | 95K | 93K | 93K | 93K | 100K | 100K | 100K | 0 |
| Retained Earnings | 236.67M | 221.5M | 186.97M | 161.51M | 153.59M | 126.34M | 124.06M | 137.71M | 127.24M | 123.19M | 143.57M | 135.66M | 123.12M | 113.43M | 102.56M | 85.44M | 82.6M | 68.18M | 61.85M | 67.71M | 83.67M | 98.11M | 83.61M | 60.98M | 45.95M | 38.26M | 30.67M | 23.9M | 22.1M | 17M | 19.5M |
| Treasury Stock | -1.2M | -1.2M | -1.2M | -1.2M | -1.2M | -1.2M | -1.2M | -1.2M | -1.2M | -1.2M | -1.2M | -1.2M | -1.2M | -1.2M | -1.2M | -1.2M | -1.2M | -1.2M | -1.2M | -1.2M | -1.2M | -1.2M | -1.2M | -1.2M | -1.2M | -1.2M | -1.2M | -1.2M | 0 | 0 | 0 |
| Accumulated OCI | 842K | 564K | 1.04M | -204K | -2.48M | -9.03M | -8.63M | -4.33M | -3.18M | -4.4M | -6.42M | -4.83M | -3.5M | -3.16M | -4.33M | -3.24M | -3.4M | -2.7M | -3.19M | -4.06M | -117.1M | -112.73M | -104.3M | -95.8M | -88.3M | -81M | -74M | -67.6M | -60.9M | -53.7M | -42.9M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Quick answers to the most common questions about buying JBSS stock.
As of 2025, John B. Sanfilippo & Son, Inc. (JBSS) had total assets of $597.6M including $346.4M in current assets.
John B. Sanfilippo & Son, Inc. (JBSS) carries total debt of $102.1M, offset by $0.6M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
John B. Sanfilippo & Son, Inc. (JBSS) has total shareholders' equity (book value) of $360.7M ($30.77 book value per share). Book value represents the net worth of the company belonging to common stock holders.
John B. Sanfilippo & Son, Inc. (JBSS) reported a current ratio of 2.22x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.
Key Metrics
Top Statement Risk
Thin cash reserves amid volatile margins
Metrics are mathematically derived from official filings.
Asset Growth Funded by Liabilities, Not Cash
Total assets have expanded from $491.9M in Q3 2024 to $658.6M in Q4 2026, a 33.9% increase, while the cash position has remained minimal, suggesting growth has been financed by leveraging operational liabilities and debt rather than accumulating liquid reserves.
The balance sheet trajectory is one of expansion, but the quality of that growth is questionable given the persistent near-zero cash balance. This pattern, combined with rising debt and liabilities, suggests the company is stretching its operational cycle to fund growth, which increases its sensitivity to any disruption in cash flow from operations, as seen in the volatile earnings-to-cash conversion noted in prior analysis.
Current Ratio Masks Operational Cash Crunch
Despite a healthy current ratio of 2.08 in Q4 2026, the company's cash on hand was a mere $1.1 million against $278.6 million in total liabilities, indicating that liquidity is heavily dependent on the swift conversion of inventory and receivables to meet obligations.
The seemingly adequate current ratio is misleading because it includes a massive inventory and receivables base relative to cash. With deferred revenue at zero, there is no pre-collected cash to bolster the liquidity position. This structure, where the balance sheet appears solvent but operations run on a very thin cash margin, makes the company highly vulnerable to any working capital missteps or delays in collections.
Low Leverage Provides Strategic Flexibility
Total debt increased to $109.3M in Q4 2026 from $46.3M a year prior, but the debt-to-equity ratio remains a conservative 0.29, well below the peer median, suggesting the company is leveraging its strong equity base for strategic purposes rather than out of financial necessity.
The significant increase in absolute debt levels over the past year contrasts with the stable, low leverage ratio. This indicates that equity has grown in tandem, likely through retained earnings. The low leverage provides a meaningful buffer against the margin pressures highlighted in prior income statement analysis, affording the company time and financial capacity to navigate commodity volatility without a refinancing crisis.
Retained Earnings Drive Equity Growth
Shareholders' equity grew to $379.9M in Q4 2026, driven almost entirely by a $49.7M increase in retained earnings since Q3 2024, implying that the business has been funding its asset expansion internally despite the minimal cash balance.
The equity build-up through retained earnings is a positive sign of fundamental profitability over time, even as quarterly cash flow remains erratic. However, the rapid growth in retained earnings without a corresponding cash build suggests these earnings are tied up in non-cash assets, likely working capital or capital expenditures. This dynamic reinforces the observation that the company's accounting profit has not fully translated into liquidity.
PPE Investment Signals Capacity Expansion
Net property, plant, and equipment surged from $155.7M in Q3 2024 to $251.4M in Q4 2026, a 61.4% increase, representing a major commitment of capital that has not yet been matched by a commensurate growth in cash generation.
The heavy investment in PPE indicates management is betting on significant volume growth or operational efficiency gains to justify the capital outlay. This represents a substantial increase in fixed costs, which could amplify the negative operating leverage seen during margin compression episodes. The goodwill balance has remained static at $11.8M, confirming this growth is organic and capacity-driven rather than acquisition-led.
The Hidden Cost of Growth
The combination of record asset growth, minimal cash reserves, and a severe quarterly margin collapse suggests the company may be pushing volume to absorb new capacity at the expense of profitability and balance sheet liquidity.
This is the core risk: the balance sheet is strengthening on paper via asset and equity growth, but it is becoming less liquid and more operationally leveraged. The strategic investment in PPE is necessary for scale but creates a higher fixed-cost base. If the Q4 margin collapse is not an anomaly but a sign of pricing power erosion in the private label market, the company could find itself with elevated fixed costs and compressed margins, straining both future cash flow and the balance sheet's defensive qualities.